Holen Sie sich die Stockscreener-App
83.40
1.72%
1.41
Schlusskurs vom Vortag:
$81.99
Offen:
$82.11
24-Stunden-Volumen:
30,160
Relative Volume:
0.42
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.48%
1M Leistung:
+7.71%
6M Leistung:
+23.08%
1J Leistung:
+22.74%
1-Tages-Spanne:
$81.95
$83.50
1-Wochen-Bereich:
$81.92
$83.85
52-Wochen-Spanne:
$58.97
$86.17
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Firmenname
Ishares U S Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IHE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
83.40 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
338.73 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
687.57 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
690.92 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
263.38 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
627.61 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Aktie (IHE) Neueste Nachrichten
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal - sharewise.com
iShares U.S. Pharmaceuticals ETF $IHE Shares Sold by Brown Advisory Inc. - Defense World
The pharmaceutical sector is surging. Here's 1 stock every investor should have on their radar. - MSN
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. - The Globe and Mail
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise.com
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - Yahoo Finance
Pharmaceutical Sector Surges on Policy Shifts and Innovation - Ad-hoc-news.de
Pharma Stocks in the World Market for TVC:GOLD by GlobalWolfStreet - TradingView
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'CVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? - sharewise.com
Pharma ETF (IHE) Hit a 52-Week High - sharewise.com
iShares U.S. Pharmaceutical ETF (NY: IHE - Markets Financial Content
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - NewsBreak: Local News & Alerts
Is iShares U.S. Pharmaceutical ETF stock a top dividend aristocrat candidateEarnings Risk Report & Daily Growth Stock Tips - newser.com
Is iShares U.S. Pharmaceutical ETF stock attractive post correctionJuly 2025 Final Week & Community Consensus Stock Picks - newser.com
Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs - TradingView
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - sharewise.com
How dovish Fed policy supports iShares U.S. Pharmaceutical ETF stockQuarterly Portfolio Summary & Expert Curated Trade Setup Alerts - newser.com
How iShares U.S. Pharmaceutical ETF stock trades under stagflationTrade Entry Summary & Weekly Setup with ROI Potential - newser.com
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Can iShares U.S. Pharmaceutical ETF stock test all time highs2025 Earnings Impact & High Conviction Trade Alerts - newser.com
Is iShares U.S. Pharmaceutical ETF stock positioned for secular growthMarket Movement Recap & High Accuracy Buy Signal Tips - newser.com
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView
Truist Financial Corp Has $593,000 Holdings in iShares U.S. Pharmaceuticals ETF $IHE - Defense World
Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock - MSN
3,967 Shares in iShares U.S. Pharmaceuticals ETF $IHE Acquired by Wealth Enhancement Advisory Services LLC - Defense World
Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors? - The Motley Fool
Can iShares U.S. Pharmaceutical ETF stock double in coming yearsQuarterly Portfolio Report & Long-Term Growth Portfolio Plans - newser.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
How iShares U.S. Pharmaceutical ETF stock trades in high volatilityJuly 2025 Earnings & Entry and Exit Point Strategies - newser.com
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Sahm
U.S. Capital Wealth Advisors LLC Has $437,000 Stock Holdings in iShares U.S. Pharmaceuticals ETF $IHE - Defense World
Trump’s Pharma Tariffs Boost US Drug Stocks as Europe’s and Asia’s Drop - NTD News
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - Yahoo Finance
Finanzdaten der Ishares U S Pharmaceuticals Etf-Aktie (IHE)
Es liegen keine Finanzdaten für Ishares U S Pharmaceuticals Etf (IHE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):